507 related articles for article (PubMed ID: 16454822)
1. The impact of antireflux surgery on oxidative stress of esophageal mucosa caused by gastroesophageal reflux disease: 4-yr follow-up study.
Rantanen TK; Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA
Am J Gastroenterol; 2006 Feb; 101(2):222-8. PubMed ID: 16454822
[TBL] [Abstract][Full Text] [Related]
2. Gastroesophageal reflux patients' defective antioxidative capacity in the proximal esophageal mucosa before antireflux surgery and also after 4-year follow-up.
Räsänen JV; Sihvo EI; Rantanen TK; Ahotupa MO; Färkkilä MA; Harjula A; Salo JA
Ann Med; 2008; 40(1):74-80. PubMed ID: 17943478
[TBL] [Abstract][Full Text] [Related]
3. Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus.
Vallböhmer D; DeMeester SR; Oh DS; Banki F; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; Chandrasoma PT; Peters JH; DeMeester TR
Am J Gastroenterol; 2006 Jul; 101(7):1458-66. PubMed ID: 16863546
[TBL] [Abstract][Full Text] [Related]
4. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
5. [Postoperative evaluation of esophageal mucosal change dynamics in patients with reflux diseases].
Wallner G; Misiuna P; Chibowski D; Polkowski W; Abramowicz K; Sory A
Wiad Lek; 1997; 50 Suppl 1 Pt 1():273-81. PubMed ID: 9446369
[TBL] [Abstract][Full Text] [Related]
6. Proliferative and anti-apoptotic activity of esophageal mucosa in gastroesophageal reflux disease is not affected by fundoplication: a 4-year follow-up study.
Rantanen TK; Oksala NK; Honkanen TT; Räsänen JV; Sihvo EI; Mattila JJ; Paimela HM; Paavonen TK; Salo JA
Eur Surg Res; 2011; 47(1):5-12. PubMed ID: 21540613
[TBL] [Abstract][Full Text] [Related]
7. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery.
Oh DS; DeMeester SR; Vallbohmer D; Mori R; Kuramochi H; Hagen JA; Lipham J; Danenberg KD; Danenberg PV; Chandrasoma P; DeMeester TR
Arch Surg; 2007 Jun; 142(6):554-9; discussion 559-60. PubMed ID: 17576892
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
9. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
Triadafilopoulos G; Kaczynska M; Iwane M
Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
[TBL] [Abstract][Full Text] [Related]
10. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery.
O'Riordan JM; Byrne PJ; Ravi N; Keeling PW; Reynolds JV
Am J Surg; 2004 Jul; 188(1):27-33. PubMed ID: 15219481
[TBL] [Abstract][Full Text] [Related]
12. Duodenogastroesophageal reflux: results of medical treatment and antireflux surgery.
Elhak NG; Mostafa M; Salah T; Haleem M
Hepatogastroenterology; 2008; 55(81):120-6. PubMed ID: 18507090
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of ablation with antireflux surgery for Barrett's esophagus: a clinical and molecular biologic study.
Kauttu T; Räsänen J; Krogerus L; Sihvo E; Puolakkainen P; Salo JA
Surg Endosc; 2012 Jul; 26(7):1892-7. PubMed ID: 22219010
[TBL] [Abstract][Full Text] [Related]
14. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus.
Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E
Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384
[TBL] [Abstract][Full Text] [Related]
15. The effect of fundoplication on proliferative and anti-apoptotic activity of esophageal mucosa in gastroesophageal reflux disease: 4-year follow-up study.
Rantanen T; Oksala N; Honkanen T; Räsänen J; Sihvo E; Mattila J; Paimela H; Paavonen T; Salo J
J Dig Dis; 2011 Aug; 12(4):263-71. PubMed ID: 21791020
[TBL] [Abstract][Full Text] [Related]
16. [Perception of symptoms with minimal reductions of esophageal pH in patients with erosive and non-erosive GERD].
Remes-Troche JM; Gómez-Escudero O; Ruíz JC; Schmulson MJ; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2004; 69(1):30-6. PubMed ID: 15193061
[TBL] [Abstract][Full Text] [Related]
17. Barrett's esophagus control after antireflux surgery.
Ochando Cerdán F; Hernández García-Gallardo D; Moreno González E
Rev Esp Enferm Dig; 2002 Apr; 94(4):188-200. PubMed ID: 12185930
[TBL] [Abstract][Full Text] [Related]
18. The use of pH monitoring and esophageal manometry in the evaluation of results of surgical therapy for gastroesophageal reflux disease.
Soyer T; Karnak I; Tanyel FC; Senocak ME; Ciftci AO; Büyükpamukçu N
Eur J Pediatr Surg; 2007 Jun; 17(3):158-62. PubMed ID: 17638153
[TBL] [Abstract][Full Text] [Related]
19. Histological and anatomic changes in Barrett's esophagus after antireflux surgery.
Low DE; Levine DS; Dail DH; Kozarek RA
Am J Gastroenterol; 1999 Jan; 94(1):80-5. PubMed ID: 9934735
[TBL] [Abstract][Full Text] [Related]
20. KTP laser ablation of Barrett's esophagus after anti-reflux surgery results in long-term loss of intestinal metaplasia. Potassium-titanyl-phosphate.
Bowers SP; Mattar SG; Waring PJ; Galloway K; Nasir A; Pascal R; Hunter JG
Surg Endosc; 2003 Jan; 17(1):49-54. PubMed ID: 12364985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
